Purpose: To explore the evaluation value of contrast enhanced ultrasound (CEUS) quantitative parameters in ischemic-type biliary lesions after liver transplantation to assist its early-diagnosis.
Methods: Patients who underwent liver transplantation and intravenous CEUS at Beijing Friendship Hospital, Capital Medical University from June 25, 2020 to December 28, 2022 and were diagnosed with Ischemic-type biliary lesions (ITBLs) by Magnetic Resonance Cholangiopancreatography (MRCP) or Endoscopic Retrograde Cholangiopancreatography (ERCP) or Percutaneous Transhepatic Cholangiography (PTC) were prospectively enrolled. SonoLiver software was used to quantitatively analyze the contrast images, transplanted livers with normal biliary tracts as the control group. SPSS 25.0 software was used to analyze the data.
Results: There was a total of 35 patients enrolled in the study, and 15 ITBLs and 30 normal biliary tract of transplanted livers, respectively. The dynamic vascular patterns (DVP) curve of the ITBLs group was negative wave, while the DVP curve of the normal biliary tract group was positive wave. Compared with the patients with normal biliary tract, the Maximum intensity (IMAX), Rise slope 50% (Rs50), Area under curve (AUC), Area under curve in Wash-in phase (WinAUC), Wash in Rate (WinR), Rise slope 10-90% (Rs1090), and Wash out Rate (WouR) of the ITBLs group were lower, while the Fall slope (Fs50) was higher. There was no significant difference in Rise time (RT), Time to Peak (TTP), Fall half time (FHT), Mean transit time (mTT), Fall time (FT), WioAUC ((WioAUC = WinAUC + WouAUC)), and Area under curve in Wash-out phase (WouAUC) between the two groups (P > 0.05). The ROC curve results showed that Fs50 > -2.64 was the cutoff value for predicting ITBLs, with an area under the curve of 0.816 (95%CI: 0.683-0.949), and a sensitivity and specificity of 0.846 and 0.607; Rs50 < 7.08, AUC < 39761.7050, WinR < 101.7 and WouR < 474.52 were the cutoff values for predicting ITBLs, with areas under the curve of 0.853 (95%CI: 0.728-0.979), 0.911 (95%CI: 0.783-1.000), 0.756 (95%CI: 0.615-0.896) and 0.700 (95%CI: 0.536-0.864).
Conclusion: The quantitative parameters of CEUS imaging, such as IMAX, Rs50, AUC, WinAUC, WinR, Rs1090, WouR, and Fs50, are helpful in predicting ITBLs and improving the reproducibility of diagnosis. The threshold of these quantitative parameters will aid in the early diagnosis of ischemic-type biliary lesions after liver transplantation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00261-024-04761-3 | DOI Listing |
Purpose: To explore the evaluation value of contrast enhanced ultrasound (CEUS) quantitative parameters in ischemic-type biliary lesions after liver transplantation to assist its early-diagnosis.
Methods: Patients who underwent liver transplantation and intravenous CEUS at Beijing Friendship Hospital, Capital Medical University from June 25, 2020 to December 28, 2022 and were diagnosed with Ischemic-type biliary lesions (ITBLs) by Magnetic Resonance Cholangiopancreatography (MRCP) or Endoscopic Retrograde Cholangiopancreatography (ERCP) or Percutaneous Transhepatic Cholangiography (PTC) were prospectively enrolled. SonoLiver software was used to quantitatively analyze the contrast images, transplanted livers with normal biliary tracts as the control group.
J Transl Med
January 2025
Department of Oncology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200092, P.R. China.
Background: The colon and rectum are highly innervated, with neural components within the tumor microenvironment playing a significant role in colorectal cancer (CRC) progression. While perineural invasion (PNI) is associated with poor prognosis in CRC, the impact of nerve density and diameter on tumor behavior remains unclear. This study aims to evaluate the prognostic value of nerve characteristics in CRC and to verify the impact of nerves on tumor growth.
View Article and Find Full Text PDFBMC Gastroenterol
January 2025
Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230022, China.
Background: CA19-9 is a classical tumor marker and plays an important role in the diagnosis of biliary and pancreatic cancer. However, a few cases reported that the tumor maker CA19-9 is abnormally elevated in patients with calculous cholecystitis, but the relation between severity of calculous cholecystitis and serum CA19-9 level are still unknown.
Methods: Total 105 calculous cholecystitis patients from first hospital were collected and divided into high serum CA19-9 group(high group, n = 35) and normal serum CA19-9 group(normal group, n = 70).
Vet Res Commun
January 2025
School of Agricultural Sciences, Innovation and Business, University of Passo Fundo, Passo Fundo, Brazil.
Choledochal cyst or biliary tract cyst is a pathological condition characterized by abnormal dilation of the hepatobiliary system. In veterinary medicine, case descriptions and histological characterizations of this biliary malformation are scarce, requiring reliance on data from human medicine. A presumptive diagnosis typically involves imaging studies, with histopathological examination required for confirmation.
View Article and Find Full Text PDFBMC Immunol
January 2025
Department of Oncology and Hematology, Oulu University Hospital, Oulu, Finland.
Vanishing bile duct syndrome (VBDS) is a serious drug induced liver injury characterized by chronic cholestasis and loss of intrahepatic bile ducts. VBDS has been reported also following checkpoint inhibitor treatment. We compared CD3 + , CD4 + , CD8 + , CD20 + , CD57 + , PD-1 + and PD-L1 + lymphocyte infiltrates in liver biopsies of patients that encountered VBDS (n = 2) or hepatotoxicity (n = 3) after pembrolizumab (n = 4) or nivolumab (n = 1) treatment with samples from normal liver (n = 10), non-alcohol steatohepatitis (NASH, n = 10), primary biliary cholangitis (PBC, n = 10) or pembrolizumab-treated patients without adverse events (n = 2).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!